Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Hematology|September 4, 2020
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world dataShinichiro Matsuda, Ritsuro Suzuki, Tsutomu Takahashi, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2005
NK-cell neoplasms in JapanKazuo Oshimi, Keisei Kawa, Shigeo Nakamura, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 3, 2024
Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in JapanMotoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, et al.
British Journal of Haematology|November 24, 2023
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, et al.
Hematological Oncology|April 10, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trialTakashi Watanabe, Kensei Tobinai, Taro Shibata, et al.
Leukemia & Lymphoma|April 7, 2010
Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomasTakashi Watanabe, Tomohiro Kinoshita, Kuniaki Itoh, et al.
The Lancet. Haematology|November 4, 2018
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trialTakashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, et al.
Leukemia|February 17, 2025
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next studyAyumi Fujimoto, Kana Miyazaki, Kimikazu Yakushijin, et al.
Pageof 8